Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0010 Transporter Info | ||||
Gene Name | SLC22A1 | ||||
Transporter Name | Organic cation transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC22A1 gene in hepatocellular carcinoma condition | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human adult hepatocellular carcinoma cells (Huh7) | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to activate the transcription of SLC22A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Organic cation transporter 1. | |||||
NR1I2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC22A1 gene in health condition | [2] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the metabolite from Host unspecified microbiota, has been reported to activate the transcription of SLC22A1 gene in health condition, which leads to an increased expression of the drug transporter Organic cation transporter 1. | |||||
Transcriptional Phenomenon 2 |
Repression of SLC22A1 gene in hepatoblastoma condition | [3] | ||||
TF Protein Name |
Nuclear receptor subfamily 1 group I member 2 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatoblastoma [ICD11: 2C12.01] | |||||
Tissue |
Liver | |||||
Related DT Changes |
down regulating | |||||
Experimental Material |
Human hepatoblastoma cells (HepG2) | |||||
Detailed Description |
Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the metabolite from Host unspecified microbiota, has been reported to repress the transcription of SLC22A1 gene in hepatoblastoma condition, which leads to a decreased expression of the drug transporter Organic cation transporter 1. | |||||
PPARA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC22A1 gene in hepatocellular carcinoma condition | [4] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor alpha | Transcription Factor Info | ||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
FVB/N mice | |||||
Detailed Description |
Peroxisome proliferator-activated receptor alpha (PPARA) has been reported to activate the transcription of SLC22A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Organic cation transporter 1. | |||||
PPARG |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC22A1 gene in hepatocellular carcinoma condition | [4] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
FVB/N mice | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG) has been reported to activate the transcription of SLC22A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Organic cation transporter 1. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC22A1 gene in health condition | [5] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor gamma | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Blood | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human vascular smooth muscle cells | |||||
Detailed Description |
Peroxisome proliferator-activated receptor gamma (PPARG), influenced by the exogenous rosiglitazone, has been reported to activate the transcription of SLC22A1 gene in health condition , which leads to an increased expression of the drug transporter Organic cation transporter 1. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC22A1 gene | [6] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Striated muscle | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC22A1 gene, which in turn affects the expression or function of the drug transporter Organic cation transporter 1. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC22A1 gene | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Liver; Lung; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC22A1 gene, which in turn affects the expression or function of the drug transporter Organic cation transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.